Haas M - Search Results

1

Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin.

Fink D, Nebel S, Norris PS, Baergen RN, Wilczynski SP, Costa MJ, Haas M, Cannistra SA, Howell SB. Fink D, et al. Among authors: haas m. Int J Cancer. 1998 Aug 31;77(5):741-6. doi: 10.1002/(sici)1097-0215(19980831)77:5<741::aid-ijc13>3.0.co;2-4. Int J Cancer. 1998. PMID: 9688308

2

In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair.

Fink D, Zheng H, Nebel S, Norris PS, Aebi S, Lin TP, Nehmé A, Christen RD, Haas M, MacLeod CL, Howell SB. Fink D, et al. Among authors: haas m. Cancer Res. 1997 May 15;57(10):1841-5. Cancer Res. 1997. PMID: 9157971

3

A fluorescent p53GFP fusion protein facilitates its detection in mammalian cells while retaining the properties of wild-type p53.

Norris PS, Haas M. Norris PS, et al. Among authors: haas m. Oncogene. 1997 Oct;15(18):2241-7. doi: 10.1038/sj.onc.1201406. Oncogene. 1997. PMID: 9393983

4

The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.

Fink D, Nebel S, Norris PS, Aebi S, Kim HK, Haas M, Howell SB. Fink D, et al. Among authors: haas m. Br J Cancer. 1998 Mar;77(5):703-8. doi: 10.1038/bjc.1998.116. Br J Cancer. 1998. PMID: 9514047 Free PMC article.

5

Evidence against ras activation in human ovarian carcinomas.

Haas M, Isakov J, Howell SB. Haas M, et al. Mol Biol Med. 1987 Oct;4(5):265-75. Mol Biol Med. 1987. PMID: 3320675

6

High-titer MSCV-based retrovirus generated in the pCL acute virus packaging system confers sustained gene expression in vivo.

Norris PS, Jepsen K, Haas M. Norris PS, et al. Among authors: haas m. J Virol Methods. 1998 Nov;75(2):161-7. doi: 10.1016/s0166-0934(98)00108-6. J Virol Methods. 1998. PMID: 9870591

7

Inhibition of T-cell acute lymphoblastic leukemia proliferation in vivo by re-expression of the p16INK4a tumor suppressor gene.

Schoppmeyer K, Norris PS, Haas M. Schoppmeyer K, et al. Among authors: haas m. Neoplasia. 1999 Jun;1(2):128-37. doi: 10.1038/sj.neo.7900021. Neoplasia. 1999. PMID: 10933047 Free PMC article.

8

Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.

Webster NJ, Resnik JL, Reichart DB, Strauss B, Haas M, Seely BL. Webster NJ, et al. Among authors: haas m. Cancer Res. 1996 Jun 15;56(12):2781-8. Cancer Res. 1996. PMID: 8665514

9

Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene.

Cheng J, Yee JK, Yeargin J, Friedmann T, Haas M. Cheng J, et al. Among authors: haas m. Cancer Res. 1992 Jan 1;52(1):222-6. Cancer Res. 1992. PMID: 1727382

10

Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells.

Yount GL, Haas-Kogan DA, Vidair CA, Haas M, Dewey WC, Israel MA. Yount GL, et al. Among authors: haas m, haas kogan da. Cancer Res. 1996 Feb 1;56(3):500-6. Cancer Res. 1996. PMID: 8564961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,142 results

Search Page

Filters